Neeraj Dhaun

Circulating microRNAs as potential markers of human drug-induced liver injury

Philip J. Starkey Lewis, James W. Dear, Vivien Platt et al. · Hepatology · 2011 · 513 citations

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

Glomerulonephritis, Active-controlled Clinical Trial, Renal Function +9

Selective Endothelin-A Receptor Antagonism Reduces Proteinuria, Blood Pressure, and Arterial Stiffness in Chronic Proteinuric Kidney Disease

Neeraj Dhaun, I. MacIntyre, D.J. Kerr et al. · Hypertension · 2011 · 156 citations · Full text

Blood Pressure–Independent Reduction in Proteinuria and Arterial Stiffness After Acute Endothelin-A Receptor Antagonism in Chronic Kidney Disease

Neeraj Dhaun, I. MacIntyre, Vanessa Melville et al. · Hypertension · 2009 · 126 citations